Avalo Therapeutics, Inc. · NASDAQ:AVTX
Neil Garry Arthur received 100,200 Avalo Therapeutics, Inc. shares as an award (Form 4)
Traded May 21, 2026 · Filed May 26, 2026
On May 21, 2026, Neil Garry Arthur (Director, Chief Executive Officer) received 100,200 Avalo Therapeutics, Inc. shares as an award, leaving 190,314 shares. Filed May 26, 2026 (Form 4).
- Awarded
- 100,200 shares
- Holding after
- 190,314 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Award | 100,200 | 190,314 | Direct |